RSS

RMHB Rocky Mountain High Brands, Inc.

Last Post: 09/27/26
Followers: 450
Posts Today: 0
Views Today: 9863

RMHB Stock Quote & Tools

$0.0014 ▲ +0.0000 (+0.00%) As of Oct 23, 2:32 PM EDT
Last0.0014
$ Chg0.0000
Open0.0014
High0.0014
Beta0.7702
Year High0.005
Market Cap1.26M
P/B Ratio-0.87
EPS-0.04
Avg Vol (30d)118.6K
Volume166.4K
% Chg+0.00%
Prev Close0.0014
Low0.0014
VWAP0.00140
Year Low0.000
Total Shares899.47M
Shares Out899.47M
Float890.47M
ExchangeOTCID
Consumer Staples Beverages - Non-Alcoholic

RMHB Stock Message Board Discussion

  1. Wodebucos

Top 10 Most Recent News Articles

LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 12

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 148

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 336

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 112

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 391

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 75

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Rockpool Acquisitions Faces Trading Suspension from FCA

Updated Category News Views 230

Trading Suspension of Rockpool Acquisitions Plc Shares LONDON - Recently, the Financial Conduct Authority (FCA) announced an immediate suspension of Rockpool Acquisitions Plc's ordinary shares from the Official List. The suspension was requested by the company itself and serves to protect the interests of investors and maintain market integrity. Details of the Suspension...

Continue Reading
Discover the Growth of Linde Stock Over the Past Decade

Updated Category News Views 262

Linde Stock Performance: A Decade in Review Linde (NASDAQ: LIN) has exhibited exceptional performance in the stock market over the past ten years, showcasing an impressive annualized return of 13.72%. This growth has outpaced the overall market by 2.12%, demonstrating the strength of Linde's business strategies and market presence. Investment Growth Over Ten Years If an...

Continue Reading
Exploring Saudi Arabia's Economic Growth Trends in Q3

Updated Category News Views 377

Saudi Arabia's Economic Overview in Q3 In a remarkable turn of events, Saudi Arabia's economy has reported a year-over-year growth of 2.8% for the third quarter. This growth, as unveiled by preliminary government statistics, has been largely fueled by robust performance in non-oil sectors, indicating a diversification effort from the nation. This positive trend is a...

Continue Reading
ANTHBOT's Quiet Drive Mirrors Athlete's Steadfastness

Updated Category News Views 4

Unveiling Consistent Performance Just like a goalkeeper defends the goal, ANTHBOT defends your lawn—silently and consistently. Partnering up with German goalkeeper Marc ter Stegen in their latest campaign, ANTHBOT is airing a TV blitz across ARD, ZDF, and digital platforms. This ain't just some ad blitz; it's a thoughtful nudge toward understanding how regular, quiet,...

Continue Reading
WisdomTree Earns 2024 Best Places to Work Honors Again

Updated Category News Views 162

WisdomTree Achieves Recognition in Employee Satisfaction WisdomTree, Inc. (NYSE: WT), known for its pioneering approach in the finance sector, has been celebrating another significant achievement. Recognized as a 2024 Best Places to Work in Money Management, this marks the fifth consecutive year the company has attained this honor. The accolades stem from a robust survey...

Continue Reading